Microbot Medical Inc.
MBOT
$1.55
-$0.13-7.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 93.92% | 226.87% | 116.94% | 47.35% | 28.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.47% | 20.64% | 17.00% | 48.27% | 26.72% |
| Operating Income | -43.00% | -20.64% | -17.00% | -48.27% | -26.72% |
| Income Before Tax | -41.14% | -2.12% | -11.26% | -41.99% | -9.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.14% | -2.12% | -11.26% | -41.99% | -9.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.14% | -2.12% | -11.26% | -41.99% | -9.70% |
| EBIT | -43.00% | -20.64% | -17.00% | -48.27% | -26.72% |
| EBITDA | -43.31% | -21.27% | -17.52% | -48.62% | -27.59% |
| EPS Basic | 34.65% | 73.90% | 61.89% | 42.23% | 50.39% |
| Normalized Basic EPS | 41.64% | 73.88% | 61.89% | 42.20% | 44.40% |
| EPS Diluted | 34.65% | 73.90% | 61.89% | 42.23% | 50.39% |
| Normalized Diluted EPS | 41.64% | 73.88% | 61.89% | 42.20% | 44.40% |
| Average Basic Shares Outstanding | 116.04% | 291.55% | 191.99% | 145.77% | 121.16% |
| Average Diluted Shares Outstanding | 116.04% | 291.55% | 191.99% | 145.77% | 121.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |